BHU professors plan clinical trial of ayurvedic drug against coronavirus





Professors on the Banaras Hindu University (BHU) have proposed to hold out a clinical trial of immunity-boosting ayurvedic drug fifatrol to test its efficacy in tackling the lethal Covid-19.



However, the proposal is but to be accepted, official sources stated.




According to professor and principal investigator for the proposed challenge Dr Okay N Dwivedi, the plan has been despatched to a job drive shaped by the federal government for scientific validation of ayurveda and conventional medicinal formulation by way of analysis establishments in tackling COVID-19.


The Interdisciplinary AYUSH Research and Development Task Force has members from the Department of Biotechnology (DBT), Council of Scientific and Industrial Research (CSIR) as additionally ayush practitioners and others. Their job is to establish potential preventive remedy and therapeutic approaches from ayush methods in several phases of Covid-19 therapy.


The AYUSH ministry had issued a notification on March 31, asking ayurveda, yoga and naturopathy, unani, siddha and homoeopathy (AYUSH) practitioners and establishments to submit their strategies on varied therapies, and has acquired over 2,000 proposals.


ALSO READ: Allow liquor sales in lockdown: Talking point for many CMs in Modi meeting


Experts say that fifatrol, enriched with immune-enhancing herbs, has been discovered to be efficient in curing main bacterial infections comparable to staphylococcus species that causes fever, cough and chilly, and pores and skin ailments amongst others.


AIMIL Pharmaceuticals, the corporate that produces fifatrol, stated that drug is used to deal with flu and viral infections of higher respiratory tract. But that is for the primary time that consultants have determined to find out if it may be useful in combating the novel


Head of the Department of Dravyaguna at Dr Dwivedi stated fifatrol is given to sufferers with signs just like COVID-19. “So, we are now trying to evaluate this drug on critically-ill COVID-19 patients to check if it can help reduce mortality,” he stated.


“During a trial on dengue patients at AIIMS, Bhopal, the drug was found to have increased platelet count significantly. The study also established that fifatrol can strengthen the liver with no systemic side effects,” the professor stated.


In reality, researchers at AIIMS, Bhopal, of their preliminary outcomes have discovered that the drug generally is a appropriate different to allopathic antibiotics with out inflicting any unwanted side effects.


“Fifatrol is an anti-microbial solution prepared from 13 key herbs including sudarshan vati, sanjeevani vati, godanti bhasma, tribhuvan kirti ras and mrityunjay ras, tulsi, kutki, chirayata, motha and giloy,” Dr Dwivedi stated.


Prime Minister Narendra Modi has additionally urged AYUSH practitioners to pitch in to deal with the pandemic. He has additionally been exhorting the residents of India to fall again on conventional house treatments throughout instances of such a worldwide well being disaster to spice up their immunity.



Leave a Reply

%d bloggers like this: